Asset Management One’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.74M | Buy |
|
|||||
|
2025
Q2 | $5.1M | Sell |
|
|||||
|
2025
Q1 | $7.43M | Sell |
|
|||||
|
2024
Q4 | $9.82M | Buy |
|
|||||
|
2024
Q3 | $7.98M | Buy |
|
|||||
|
2024
Q2 | $9.3M | Buy |
|
|||||
|
2024
Q1 | $5.16M | Buy |
|
|||||
|
2023
Q4 | $4.91M | Sell |
|
|||||
|
2023
Q3 | $4.35M | Buy |
|
|||||
|
2023
Q2 | $3.63M | Buy |
|
|||||
|
2023
Q1 | $3.65M | Buy |
|
|||||
|
2022
Q4 | $4.32M | Sell |
|
|||||
|
2022
Q3 | $4.04M | Buy |
|
|||||
|
2022
Q2 | $3.7M | Sell |
|
|||||
|
2022
Q1 | $3.56M | Sell |
|
|||||
|
2021
Q4 | $3.25M | Sell |
|
|||||
|
2021
Q3 | $3.76M | Buy |
|
|||||
|
2021
Q2 | $3.8M | Sell |
|
|||||
|
2021
Q1 | $3.9M | Sell |
|
|||||
|
2020
Q4 | $4.07M | Sell |
|
|||||
|
2020
Q3 | $4.94M | Sell |
|
|||||
|
2020
Q2 | $6.3M | Buy |
|
|||||
|
2020
Q1 | $3.73M | Sell |
|
|||||
|
2019
Q4 | $6.27M | Buy |
|
|||||
|
2019
Q3 | $1.44M | Hold |
|
|||||
|
2019
Q2 | $1.35M | Buy |
|
|||||
|
2019
Q1 | $930K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $197K | Sell |
|
|||||
|
2016
Q3 | $7.69M | Sell |
|
|||||
|
2016
Q2 | $7.73M | Sell |
|
|||||
|
2016
Q1 | $6.83M | Buy |
|
|||||
|
2015
Q4 | $8.67M | Buy |
|
|||||
|
2015
Q3 | $5.13M | Sell |
|
|||||
|
2015
Q2 | $9.2M | Buy |
|
|||||
|
2015
Q1 | $8.04M | Sell |
|
|||||
|
2014
Q4 | $4.96M | Buy |
|
|||||
|
2014
Q3 | $2.49M | Buy |
|